Most electronic cigarettes (e-cigs) contain a nicotine-based liquid that is vaporized or inhaled. Because manufacturers present e-cigs as trendy, acceptable, a method to quit smoking and possibly a healthier alternative to cigarette smoking, the e-cig market has been growing rapidly; despite this, and limited FDA oversight, their health risks are largely unknown. The goal of this study is to investigate toxic effects of e-cig use on the human lungs and airways. This study will provide useful feasibility data to directly assess e-cig toxicity.
Min-Ae Song, PhD, Post-doctoral Researcher, Comprehensive Cancer Center, The Ohio State University
Peter Shields, MD, Professor, College of Medicine, Deputy Director, Comprehensive Cancer Center, The Ohio State University
Mahmoud H. Abdel-Rasoul, MS, MPH, Biostatistician, Center for Biostatistics, The Ohio State University
Amy M. Lehman, MAS, Senior Biostatistician, Center for Biostatistics, The Ohio State University
Mark D. Wewers, MD, Professor and Physician, Pulmonary, Allergy, Critical Care & Sleep, College of Medicine, The Ohio State University
Edwin Jackson, DO, Pulmonary Disease Specailist, The Ohio State Univesity